GMP VS ISO IN A BLOOD ESTABLISHMENT
THE ROLE OF THE NATIONAL BLOOD CENTRE IN A COUNTRY WITH A MIXED SYSTEM OF BLOOD SERVICES
CONSOLIDATION OF LABORATORIES FOR BLOOD TESTING
BLOOD APHAERESIS IN BEIJING
HEPATITIS B UPDATE ON DIAGNOSTIC AND SCREENING TEST
PLATELET ANTIBODY TESTING AS PART OF PRE-TRANSFUSION TESTING FOR MULTI-TRANSFUSION PATIENTS WHO HAD PLATELET REFRACTORINESS
OVERCOMING RESOURCE LIMITATIONS OF BLOOD SERVICES IN INDONESIA
OVERCOMING RESOURCE LIMITATION IN MYANMAR
OVERCOMING RESOURCE LIMITATIONS IN PAPUA NEW GUINEA
MOLECULAR APPLICATIONS IN ROUTINE TRANSFUSION TESTING
HOW DO WE APPROACH DILEMMAS IN RED CELL TESTING?
HOW DO WE MANAGE PATIENTS WITH RARE BLOOD TYPES
APPLYING BEHAVIOUR CHANGE THEORY TO BLOOD DONOR RECRUITMENT AND RETENTION
NEW DEVELOPMENTS IN PLASMA DERIVATIVES PRODUCTION
THERAPEUTIC APHERESIS
THE EFFECTS OF 22°C AND 4°C STORAGE OF PLATELETS ON VASCULAR ENDOTHELIAL INTEGRITY IN VITRO AND IN VIVO
A MURINE MODEL OF FOETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY CD36 ANTIBODIES
DEGLYCOSYLATED HUMAN MONOCLONAL ANTIBODY AGAINST HPA-1A PREVENTS PLATELET CLEARANCE AND ENDOTHELIAL DYSFUNCTION MEDIATED BY ANTI-HPA-1A ALLOANTIBODIES
MICRORNA EXPRESSION PROFILES AND TARGET GENE ANALYSIS IDENTIFIED A NOVEL MIRNA REGULATOR OF OK/BSG
ANTIGEN-DECORATED ENGINEERED RED BLOOD CELLS AS A NOVEL IMMUNE TOLERANCE-INDUCING AGENT
CRITICAL ROLE OF TGF- β1 IN EXPANDING HUMAN NATURAL REGULATORY T CELLS AND STABILIZING NTREGS UNDER INFLAMMATORY CONDITIONS
WHY BLOOD GROUP O PROTECTS YOU AGAINST MALARIA
RARE BLOOD TYPES IN THE ASIA PACIFIC REGION
THE EVOLVING ROLE OF PLATELET ANTIGENS AND ANTIBODIES
PLANNING DONOR RECRUITMENT STRATEGIES WITH AN EYE ON THE FUTURE
CHOOSING THE RIGHT CRITERIA FOR DONOR HEALTH AND SAFETY
ADVANCES IN BLOOD STORAGE BAGS AND PRESERVATIVE SOLUTIONS
RED BLOOD CELL GENOTYPING IN CHINA
THE RELEVANCE OF PLATELET ANTIGEN/ANTIBODIES IN MULTI ETHNIC IN MALAYSIA
GLYCOSYLATION OF ALLOANTIBODIES AGAINST BLOOD CELL ANTIGENS
ADSORPTION OF AUTO- ANTIBODIES IN PATIENTS WITH AIHA HELPS TO DETECT MASKED ALLO- ANTIBODIES TO IMPROVE SAFETY OF BLOOD TRANSFUSION
TO STUDY THE EFFICACY OF CROSS-MATCH COMPATIBLE PLATELETS IN MULTI-TRANSFUSED ALLO-IMMUNIZED HEMATOLOGY-ONCOLOGY PATIENTS REFRACTORY TO PLATELET TRANSFUSION
UPDATES ON DONOR RECRUITMENT AND MANAGEMENT IN BLOOD SERVICE
BAA BAA BLOOD SHEEP
CELLULAR THERAPY ACROSS ASIA: HARMONISATION AND CHALLANGES
ASSESSING THE RISK OF TRANSFUSION-TRANSMITTED EMERGING INFECTIOUS DISEASES
ROLE OF A PERFUSIONIST IN PATIENT BLOOD MANAGEMENT
GETTING THE RIGHT UNIT TO THE RIGHT PATIENT – HOW CAN WE FIX THE PROBLEM
FIRST STEPS INTO LEAN AT THE AUSTRALIAN RED CROSS BLOOD SERVICE
HEMOVIGILANCE AND PATIENT BLOOD MANAGEMENT: A FRESH PERSPECTIVE
GOVERNANCE AND CLINICAL TRANSFUSION
A SUCCESSFUL AND SUSTAINED MULTI-SITE PLATELET WASTAGE MINIMISATION PROGRAM
THE PROBLEM WITH HEPATITIS
PATHOGEN REDUCTION TECHNOLOGY – IS IT TIME?
THE CURRENT STATUS OF NUCLEIC ACID AMPLIFICATION TECHNOLOGY IN TRANSFUSION TRANSMITTED INFECTIOUS DISEASE TESTING
AUTOMATING THE PRODUCTION OF BLOOD COMPONENTS
INTRODUCING NOVEL BLOOD COMPONENTS – PRINCIPLES AND PRACTICE
GMP SUPERVISION ON BLOOD ESTABLISHMENT
A PRIMER ON MALARIA IN THE ASIA PACIFIC
NEW STRATEGIES FOR BACTERIAL CONTAMINATIONS
DEVELOPMENT OF A HIGHLY SENSITIVE DETECTION METHOD FOR BACTERIAL DNA IN BLOOD FOR TRANSFUSION
TRANSFUSION RISK FROM EMERGING PATHOGENS IN THE ASIA-PACIFIC REGION
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) OUTBREAK IN SOUTH KOREA: RISK MANAGEMENT AT THE KOREAN RED CROSS SEOUL NAMBU BLOOD CENTER
WHAT'S THE RIGHT MODEL FOR A NATIONAL BLOOD PROGRAMME?
PUTTING IN PLACE A RISK-BASED DECISION FRAMEWORK FOR BLOOD SAFETY
HAEMOVIGILANCE-SETTING UP ONE FROM NONE
HAEMOGLOBINOPATHIES IN INDONESIA
OPTIMISING TRANSFUSION THERAPY IN THE CHRONICALLY TRANSFUSED PATIENTS
INTRODUCTION OF POINT-OF-CARE TESTING AND INTERVENTION IN THE TRANSFUSION UNIT DECREASES PERIOPERATIVE BLEEDING, SHORTENS OPERATIVE TIME AND FACILITATES APPROPRIATE DOSAGE OF BLOOD TRANSFUSIONS
RISKS AND BENEFITS OF ANTIFIBRINOLYTIC THERAPY WITH TRANEXAMIC ACID VARY BY CARDIOVASCULAR SURGERY TYPE
A COMPARISON OF PLATELETS TRANSFUSION PRACTICE IN DENGUE HOSPITALIZED PATIENTS DURING SEPARATE OUTBREAK YEARS – 2005 VS 2013
UPDATE ON MANAGEMENT OF HEMOGLOBINOPATHIES AND IRON OVERLOAD: BEYOND BLOOD TRANSFUSION
UPDATE ON INDICATIONS FOR RED CELL TRANSFUSION
AN UPDATE ON INDICATIONS FOR PLATELET TRANSFUSION
P-001
INFRASTRUCTURE OF BLOOD TRANSFUSION ROOMS AT IN-PATIENT FACILITIES IN KAZAKHSTAN
A BRIEF LOOK, WORK LOAD AND SUPERVISION OF A DAY CARE CENTER IN A TERTIARY LEVEL HOSPITAL BSMMU, BANGLADESH A FOUR YEAR STUDY
STANDARDIZED 2D LABEL DESIGN FOR BLOOD PRODUCTS
SOLVENT DETERGENT PLASMA STANDARDIZED LABEL
METRICS FOR ACCEPTANCE TESTING FOR EGYPTIAN BLOOD MANAGEMENT SYSTEM (BMS)
TESTING SECURITY OF THE BLOOD MANAGEMENT SYSTEM, THROUGH THE USAGE OF NON FUNCTIONAL TESTING, IN THE NATIONAL BLOOD TRANSFUSION CENTRE (NBTC), CAIRO, EGYPT
BENEFITS OF IMPLEMENTATION OF BLOOD DONORS DATA BASE MANAGEMENT SYSTEM VS MANUAL RECORDING SYSTEMS IN DAR EL SALAM REGIONAL BLOOD TRANSFUSION CENTER
IMPACT OF INFORMATION TECHNOLOGY IMPLEMENTATION IN MOBILE UNIT TO TRANSMITTED TRANSFUSION INFECTION RATE
INCREASED PRODUCTIVITY WITH A PAPERLESS WORKING ENVIRONMENT AT APHERESIS
RESULTS OF ESTABLISHMENT OF WALK-IN BLOOD DONOR PANELS ON ISLAND AND REMOTE AREAS IN VIETNAM
A REVIEW OF SEGMENT TESTING ON OLYMPUS PK AND THE DESIGN OF AN AUTOMATED SEGMENT CUTTER
EFECTIVITY AND COMPARATION CHECKING HAEMOGLOBIN USING CUPRIC SULFATE WITH HB CHECKER
RED CELL SEROLOGY WORKSHOP
ACHIEVING STANDARDISATION OF EGYPTIAN BLOOD TRANSFUSION PRACTICES, THROUGH A NATIONWIDE TRAINING PROGRAMME ON THE IMPLEMENTATION OF THE EGYPTIAN NATIONAL BLOOD TRANSFUSION STANDARDS
WHO WORKSHOP 2014: THE BLOOD TESTING, RISK ASSESSMENT, ENFORCEMENT AND IMPLEMENTATION AS PART OF GOOD MANUFACTURING PRACTICES (GMP) IN BLOOD ESTABLISHMENT IN INDONESIA
P-017
INDONESIAN APHERESIS EDUCATION EXPERIENCE
DEVELOPING HUMAN CAPITAL IN GLOBAL TRANSFUSION SAFETY RESEARCH: A MID-COURSE ASSESSMENT OF THE PROGRAM
P-020
RETROSPECTVE AUDIT ON THE APPROPRIATENESS OF PLATELETS USAGE IN A TERTIARY HOSPITAL IN SINGAPORE
ANALYSIS OF TRANSFUSION REQUIREMENTS AND FACTORS PREDICTING PERI-OPERATIVE BLOOD AND BLOOD COMPONENT TRANSFUSION IN PATIENTS UNDERGOING RENAL TRANSPLANT
P-023
A STUDY OF BLOOD UTILIZATION TREND IN A TERTIARY CARE HOSPITAL LOCATED IN THE FOOTHILLS OF HIMALAYAS IN NORTHERN INDIA
SUPERVISION AND COMMUNICATION WITH THE BLOOD BANKS EFFECTIVE FOR IMPROVING BLOOD SAFETY IN JAKARTA PROVINCE
KOREAN RED CROSS BLOOD SERVICE HEADQUARTERS' RISK MANAGEMENT OF MERS-COV OUTBREAK
THE RESULTS OF EXTERNAL PROFICIENCY TESTS FOR HBSAG AND ANTI-HCV DONOR TESTING IN BLOOD CENTERS IN KOREA (2012–2014)
ENVIRONMENTAL MONITORING ABOUT BACTERIA TO BLOOD PRODUCTS STORAGE, INCLUDING RED BLOOD CELL, PLATELET AND PLASMA
STUDY OF DIFFERENT FACTORS OF BLOOD BANK REFRIGERATORS AND REFRIGERATED CENTRIFUGES USED IN IRANIAN BLOOD BANKS (IBTO) CENTERS
AN INSTITUTIONAL EFFORT AT MONITORING QUALITY OF PACKED RED CELLS AND PLATELET CONCENTRATES
ANALYSIS AND CLINICAL AUDIT OF UNUSED PLATELET CONCENTRATES IN H. ADAM MALIK HOSPITAL MEDAN INDONESIA
QUALITY ANALYSIS OF PRE-OPERATIVE PREPARED PACKED RED CELLS STUDY OF INDEXES RBC, CULTURE AND IDENTIFICATION OF BACTERIA
TRANSFUSION REACTIONS AS AN INDICATOR OF SERVICE QUALITY OF BLOOD TRANSFUSION IN SANGLAH HOSPITAL DENPASAR BALI
P-034
THE IMPORTANCE-PERFORMANCE ANALYSIS APPROACH IN CUSTOMER SATISFACTION SURVEY TO IMPROVE DONOR SERVICES IN JAKARTA BLOOD TRANSFUSION UNIT
COMPARISON QUALITY WITH FINANCING IN TANGERANG CITY BLOOD CENTRE
FREQUENT WHOLE BLOOD AND APHERESIS DONORS: UNDERSTANDING CHARACTERISTICS AND RETURN BEHAVIOUR
SOME CHARACTERISTIC FACTORS ASSOCIATED WITH DONOR RECRUITMENT
RECRUITMENT STRATEGIES FOR INCREASING NON-REMUNERATED VOLUNTARY DONOR AT FASTING MONTH IN JAKARTA BLOOD TRANSFUSION UNIT
P-040
PUBLIC AWARENESS, ATTITUDE AND PRACTICES OF BLOOD DONATION AMONG THE GENERAL POPULATION LIVING IN RIYADH, SAUDI ARABIA
A STUDY ON THE EFFECTIVENESS OF ADVERTISEMENTS AT THE WOODLANDS SATELLITE BLOOD BANK
KNOWLEDGE, ATTITUDES AND BELIEFS TOWARDS VOLUNTARY BLOOD DONATION AMONGST UNDERGRADUATE MEDICAL STUDENTS AT A TERTIARY HEALTHCARE INSTITUTION IN UTTARAKHAND, INDIA
KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS WALK-IN BLOOD DONATION AMONG INHABITANTS OF SOME ISLANDS AND REMOTE DISTRICTS IN VIETNAM
WHY WOMEN DON'T GIVE BLOOD? BACKGROUND
DATA ANALYSIS OF BLOOD DONORS POST 2014 KAOHSIUNG GAS EXPLOSIONS
ANALYSIS ON THE CHARACTERISTICS OF BLOOD DONORS IN KOREA, 2011–2013
DEFERRED DONORS IN R. MACEDONIA IN THE YEAR 2014
EVALUATION AND PATTERN OF DONOR DEFERRAL IN A TERTIARY LEVEL HOSPITAL, BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY, DHAKA
PROMOTION OF BLOOD DONATION PROGRAMS DURING FASTING MONTH BY PARTICIPATION OF GROUP DONATION IN TANGERANG BLOOD CENTRE
P-051
ANALYSIS OF RISK FACTORS LEADING TO NON COMMUNICABLE DISEASES AMONG A GROUP OF BLOOD DONORS AND ORGANIZERS OF BLOOD DONOSR SESSIONS
P-053
IMPLEMENTATION OF PRODUCTIVE APHERESIS IMPROVES PLATELET TRANSFUSION SAFETY OF POLYTRANSFUSED PEDIATRIC PATIENTS
INCREASING THE NUMBER OF VOLUNTARY BLOOD DONORS IN TANGERANG OF BLOOD CENTRE FROM 2011 UNTIL 2014
THE CAUSE OF THE BLOOD COLLECTION'S FAILURE ON BLOOD DONOR BEGINNERS IN BLOOD DONOR SERVICES
DONOR ARM PREPARATION TECHNIQUE EFFICACY EVALUATION
VALIDATION OF THE HAEMOGLOBIN COLOUR SCALE IN BLOOD DONORS IN MALAWI
PERIPHERAL BLOOD STEM AND PROGENITOR CELL COLLECTION BY TWO SEPARATORS: A PROSPECTIVE RANDOMIZED MULTICENTER STUDY
THE ADVANTAGE OF PLATELET INCREMENT ON PEDIATRICS AFTER PLATELETPHERESIS' TRANSFUSION AT HERMINA HOSPITAL
SINGLE & DOUBLE DOSE PLATELETPHERESIS DONATION AND PLETELETPHERESIS DEMAND IN TANGERANG CITY BLOOD CENTRE
DELAYED VASOVAGAL REACTIONS FOLLOWING BLOOD DONATION
THE RELATIONSHIP BETWEEN DONOR'S DIET SHORTLY BEFORE DONATION AND SPORT ACTIVITY WITH TOTAL CHOLESTEROL AND TRIGLYCERIDES LEVEL IN JAKARTA BLOOD TRANSFUSION UNIT
HAEMOVIGILANCE OF BLOOD DONORS: IMPACT OF PRE-DONATION COUNSELING ON DONOR REACTION
SOME CHARACTERISTIC FACTORS ASSOCIATED WITH ADVERSE REACTIONS IN WHOLE BLOOD DONATION
OMAN EXPERIENCE AFTER IMPLEMENTING DONOR HEMOVIGILANCE (DHV) AT CENTRAL BLOOD BANK, DEPARTMENT OF BLOOD SERVICES, MUSCAT
HEMOLYSIS POTENCY OF WASHED ERYTHROCYTE AND IN-LINE RED CELL LEUKODEPLETED COMPONENTS
COMPARATIVE STUDY OF THE PERCENTAGE OF HAEMOLYSIS OF RED BLOOD CELLS STORED IN TWO DIFFERENT ADDITIVE SOLUTIONS: SAGM AND AS-1
OSMOTIC FRAGILITY TEST OR HEMOLYSIS, WHICH ONE IS MORE WORTHY FOR BLOOD CENTRE?
BLOOD SEPARATION AND STORAGE WITH A NEW GRAVITY DRIVEN DEVICE
P-071
EVALUATION OF THE TERUMO PENPOL TOP AND BOTTOM BLOOD BAGS USING A T-ACE II+ AUTOMATIC COMPONENT EXTRACTOR AT WPBTS IN SOUTH AFRICA
THE EFFECT OF PRE-STORAGE LEUKOREDUCTION FILTRATION ON SOLUBLE HUMAN LEUKOCYTE ANTIGEN-I LEVELS IN PLATELET CONCENTRATE
VALIDATION OF RAD SOURCE RS3400 X-RAY IRRADIATOR FOR THE IRRADIATION OF BLOOD AND BLOOD COMPONENTS
EFFECT OF LEUKODEPLETION AND PATHOGEN INACTIVATION ON PLATELET CONCENTRATES
NCI CAIRO UNIVERSITY EXPERIENCE IN MANUAL VS AUTOMATED BLOOD COLLECTION
THE USE OF WASHED ERYTHROCYTE (WE) FOR CLINICAL TRANSFUSION PRACTICE IN INDONESIA: SHOULD IT BE RETAINED OR SHIFT TO OTHER ALTERNATIVES?
ANALYSIS OF ERYTHROCYTE FRAGILITY AND POTASSIUM LEVELS IN PACKED RED CELL COMPONENTS AFTER IRRADIATION WITH VARIOUS DOSES
EFFECTIVENESS OF LEUCOCYTE AND CYTOKINE REDUCTION ON BUFFY COAT DEPLETED PACKED RED CELL AND MODIFIED BED SIDE LEUKOFILTERED PACKED RED CELL
FULLY AUTOMATED PREPARATION OF WASHED PLATELET CONCENTRATES IN BRS-A PLATELET ADDITIVE SOLUTION WITH A CLOSED-SYSTEM CELL PROCESSOR
EFFECT OF LIPID STATUS OF THE DONOR PLATELET APHERESIS TO CONTENT OF PLATELETS AND LEVELS OF MALONDIALDEHYDE WITH IN STORAGE
L-CARNITINE EFFECTIVELY IMPROVES THE METABOLISM AND QUALITY OF PLATELET CONCENTRATES DURING STORAGE
INFLUENCE OF DIFFERENT METHODS PREPARATION ON PLATELET ACTIVATION IN STORED PLATELET CONCENTRATES
CENTRIFUGATION SPEED AND TIME FOR PREPARATION OF PLATELET CONCENTRATE BY PRP METHOD. IS IT AFFECTED BY BLOOD BAG TYPE?
COAGULATION FACTORS, THROMBIN FORMATION AND CLOT FORMATION OF THAWED FRESH FROZEN PLASMA
AGGREGATION AND RELEASE OF PRO-COAGULANT TISSUE FACTOR-EXPRESSING MICROPARTICLES BY THP-1 MONOCYTIC CELLS ACTIVATED BY PLATELET-DERIVED MICROPARTICLES IN VITRO
EFFECT OF FREEZING TECHNIQUE ON THE QUALITY OF FRESH FROZEN PLASMA
PROCESSING PRC LEUCOREDUCE PRODUCTION IN TANGERANG BLOOD CENTRE PERIOD JANUARY–JUNE 2015
DETECTING YELLOWISH PLASMA IN BLOOD COMPONENTS FOR IMPROVING BLOOD DONOR SERVICE IN JAKARTA BLOOD TRANSFUSION UNIT
TTHE USE OF BLOOD COMPONENT FOR TRANSFUSION BY BACKGROUND DISEASE/REASON TRANSFUSION IN BLOOD TRANSFUSION CENTER TANGERANG CITY
CERULOPLASMIN ISOLATION FROM CRYOSUPERNATANT BY ION EXCHANGE CHROMATOGRAPHY
P-092
P-093
EVALUATION OF SINGLE AND DOUBLE DOSE, INTERCEPT-TREATED, POOLED RANDOM DONOR PLATELETS SUSPENDED IN 100% PLASMA
AN OBSERVATIONAL STUDY TO EVALUATE THE THERAPEUTIC EFFICACY AND SAFETY OF PLATELET COMPONENTS PREPARED WITH THE INTERCEPT BLOOD SYSTEM
COMPARATIVE EFFECTIVENESS OF PLASMA PREPARED WITH AMOTOSALEN-UVA (INTERCEPT) PATHOGEN INACTIVATION FOR THERAPEUTIC PLASMA EXCHANGE AND LIVER TRANSPLANT
INACTIVATION OF DENGUE AND CHIKUNGUNYA VIRUSES WITH THE THERAFLEX MB-PLASMA SYSTEM
EVALUATION OF TWO HUMAN PLATELET LYSATES SUPPLEMENTS TO SUPPORT EX VIVO EXPANSION OF BOVINE CORNEAL ENDOTHELIAL CELLS AND HUMAN UMBILICAL CORD BLOOD WHARTON'S JELLY MESENCHYMAL STEM CELLS
PLATELETS AS DRUG DELIVERY SYSTEM OF DOXORUBICIN FOR BREAST CANCER THERAPY
P-100
EVALUATION OF THE ROCHE COBAS® MPX 6800 AUTOMATED SYSTEM FOR NUCLEIC ACID TESTING IN BLOOD DONORS
SPECIFICITY STUDY OF THE COBAS MPX TEST ON THE COBAS 6800 SYSTEM AT NATIONAL BLOOD CENTER, THE THAI RED CROSS SOCIETY
HEAD-TO-HEAD COMPARISON OF THE NEW ROCHE COBAS 8800 AND THE GERMAN RED CROSS NAT-SYSTEM ZELOS X100
NRL BLOOD SCREENING EQAS: UPDATE 2014
IMPACT OF NUCLEIC ACID AMPLIFICATION TEST ON SCREENING OF BLOOD DONORS IN NORTHERN PAKISTAN
NUCLEIC ACID TESTING FOR SCREENING BLOOD DONATION AT REGIONAL BLOOD CENTRE X CHIANG MAI, THAILAND
IMPLEMENTATION OF MULTI-DYE NUCLEIC ACID TESTING FOR BLOOD SCREENING IN DELHI, INDIA
THE IMPORTANCE OF NUCLEIC ACID TEST FOR IMPROVING BLOOD SAFETY IN JAKARTA BLOOD TRANSFUSION UNIT
NAT EXPERIENCE AT CHARITABLE BLOOD BANK IN PUNE, WESTERN PART OF INDIA
IMPROVING BLOOD SCREENING IN THE REPUBLIC OF KAZAKHSTAN
PERFORMANCE AND CLINICAL USEFULLNESS OF NANOPOROUS SOL-GEL BASED MICROARRAYS AS SCREENING TESTS OF BLOOD DONORS FOR PREVENTION OF TRANSFUSION-TRANSMITTED INFECTION WITH HBV, HCV AND HIV
CURRENT STATE OF NUCLEIC ACID AMPLIFICATION TESTING INCONCLUSIVE DONORS WHO ARE REACTIVE AT DISCRIMINATORY HEPATITIS B VIRUS NUCLEIC ACID AMPLIFICATION TESTING IN THE LATER DONATION IN KOREA
USEFULNESS OF SIGNAL TO CUTOFF RATIO OF HEPATITIS C VIRUS ANTIBODY ASSAY IN PREDICTING HEPATITIS C VIRUS INFECTION AMONG BLOOD DONORS
COMPARISON OF TWO ALGORITHMS TO CONFIRM AND DISCRIMINATE SAMPLES INITIALLY REACTIVE FOR NUCLEIC ACID AMPLIFICATION TESTS
ABILITY OF HCV ANTIGEN AND ANTIBODY SCREENING ASSAY TO IMPROVE BLOOD SAFETY
COMPARISON OF FOUR COMMERCIAL SCREENING ASSAYS FOR DIAGNOSIS OF HEPATITIS C
P-117
THE PREVALENCE OF TRANSFUSION-TRANSMITTED INFECTION AMONG BLOOD DONORS IN THE LOWER NORTHEASTERN REGION OF THAILAND FROM 2005 TO 2014
COMPARISON OF THE RESULTS OF THE CONFIRMATORY ASSAY FOR THE ANTI-HTLV POSITIVE DONORS
COMPARISON OF FOUR COMMERICAL SCREENING ASSAYS FOR DIAGNOSIS OF HUMAN T_CELL LYMPHOTROPIC VIRUS TYPES 1AND 2
PERFORMANCE CHARACTERISTICS OF EIA AND NAT FOR HBV/HCV/HIV AND MAIN RISK OF TTID IN SOUTHERN CHINA
VALIDATION OF IMMUNOASSAYS FOR THE USE WITH CADAVERIC SPECIMENS FROM TISSUE DONORS
HEPATITIS B VIRUS PREVALENCE IN FIRST-TIME U.S. BLOOD DONORS, 2004–2014
RESULTS OF SCREENING FOR OCCULT HEPATITIS B VIRUS INFECTION AMONG BLOOD DONORS IN MONGOLIA
ASSESSMENT OF AN HBSAG COMMERCIAL ASSAY WITH A PANEL OF WELL CARACHTERIZED MUTANTS SAMPLES
COMPARISON STUDY WITH ENZYME IMMUNOASSAY AND CHEMILUMINESCENCE IMMUNOASSAY FOR HEPATITIS B VIRUS SURFACE ANTIGEN DETECTION
P-127
EFFECT OF THE SAMPLES SENSITIVITY ANTI-HIV SCREENING
EVALUATION OF THE SENSITIVITY AND SPECIFICITY OF USE OF GLUCOSE AND PH FOR BACTERIAL SCREENING OF PLATELET CONCENTRATES COMPARED TO THE BACT/ALERT
SCREENING OF BLOOD DONORS WITH MICROSCOPY, ANTIGEN RAPID TESTS AND ANTIBODY RAPID TESTS, POLYMERASE CHAIN REACTION AGAINST MALARIA PARASITE IN AMBON CITY, INDONESIA
COBAS® CHIKV/DENV INVESTIGATIONAL ASSAY: A NOVEL HIGHLY SENSITIVE AND REPRODUCIBLE ASSAY FOR BLOOD SCREENING ON THE COBAS® 6800/8800 SYSTEM
THE SEARCH FOR DENGUE VIRUS IN AUSTRALIAN BLOOD DONATIONS DURING LOCAL OUTBREAKS
HEPATITIS E VIRUS INFECTIONS IN TRAVELLERS: A THREAT IN AUSTRALIA?
DETECTION OF HEPATITIS E VIRUS IN AUSTRALIAN BLOOD DONATIONS
COMPARISON OF THE ANTI-HEV SCREENING TEST RESULTS FOR KOREAN BLOOD DONORS
PREVALENCE OF HEPATITIS E VIRUS INFECTION AMONG IRANIAN BLOOD DONORS
MOLECULAR MODELING OF LINEAR AND CONFORMATIONAL EPITOPES OF RHD VARIANT DVII
EXTENDED RED CELL PHENOTYPE USING THE OLYMPUS PK7300 DIAGAST REAGENTS
SEEKING FOR POSITIVE DIA AND MIA ANTIGEN RED CELLS USING RED CELL POOLING ON COLUMN AGGLUTINATION TECHNIQUE: EXPERIENCE FROM TERTIARY CARE HOSPITAL, BANGKOK, THAILAND
PERFORMANCE EVALUATION OF AN AUTOMATED IMMUNOHEMATOLOGIC ANALYZER FOR TESTING ABO ANTIBODY TITERS
EFFECTIVENESS OF BLOOD GROUPING AUTOMATION METHOD ON ABO SUBGROUP DETECTION IN JAKARTA BLOOD TRANSFUSION UNIT
DEVELOPING RED CELL ANTIGEN DATABASES OF BLOOD DONOR FOR HAVING HOMEBREW PANEL CELLS IN JAKARTA BLOOD TRANSFUSION UNIT
P-143
P-144
ALLO-ANTIBODIES MASKED BY AUTO-IMMUNE COLD ANTIBODIES IN REGULARLY TRANSFUSED EGYPTIAN PATIENTS
P-146
STUDY ON RATE AND CHARACTERISTIC OF IRREGULAR ANTIBODIES OF THALASSEMIA PATIENTS AT NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION, VIETNAM (2013–2015)
THE IMPLEMENTATION OF ANTIBODY SCREENING IN PRE-TRANSFUSION TESTING FOR PATIENT SAFETY IN JAKARTA BLOOD TRANSFUSION UNIT
P-149
DETECTION OF CIS -AB USING A MICROPLATE-BASED SYSTEMS AND TWO COLUMN AGGLUTINATION TEST IN A HOSPITAL BLOOD BANK
PAROXYSMAL COLD HEMOGLOBINURIA: ROLE OF HOSPITAL TRANSFUSION MEDICINE & IMMUNOHEMATOLOGY DEPARTMENT IN THE DIAGNOSIS
PREDICTIVE VALUE OF ANTI-D SUBCLASESS IN HEMOLITIC DESEASE OF THE NEWBORN
BLOOD GROUP ANTIBODY PROFILE ON ICTERIC NEONATUS IN PERSAHABATAN GENERAL HOSPITAL
A CASE OF RARE JRA ANTIGEN-NEGATIVE AND ANTI-JRA ANTIBODY POSITIVE PATIENT WHO NEEDED EMERGENCY A BLOOD TRANSFUSION
SEVERE ALLOIMMUNIZATION, CAUSE OF DEATH IN PATIENTS WITH CHRONIC TRANSFUSION (THALASSEMIA)
A CASE REPORT OF PATIENTS WITH ANTI-C,D TRANSFUSED WITH RR AND ‘MIA’ ANTIGEN NEGATIVE PACKED RBC: INCLUDING CONSIDER TO HLA-DR TYPING
SHOULD WE DO DIRECT COOMBS TEST IN BLOOD DONOR ROUTINELY?
TNF-α AND TGF- β LEVEL AFTER INTRAOPERATIVE ALLOGENEIC RED BLOOD CELL TRANSFUSION IN ORTHOPEDIC OPERATION PATIENTS
A NOVEL PROMOTER MUTATION (−76 G>C) IN THE ABO GENE IDENTIFIED FROM THREE INDIVIDUALS WITH A3 PHENOTYPE
P-160
A CIS-AB04 ALLELE WITH A NONSYNONYMOUS SUBSTITUTION C796A IN EXON 7 OF ABO GENE IDENTIFIED IN A KOREAN FAMILY: THE FIRST CASE IN KOREA
KLF1 MUTATIONS IN JAPANESE WITH IN (LU) PHENOTYPE
INVESTIGATION OF A PATIENT WITH A PAN-REACTIVE RED CELL ANTIBODY INHIBITED BY SOLUBLE CD 55: MPS REVEALS A HOMOZYGOUS NOVEL CROMER BLOOD GROUP ALLELE
PRODUCTION OF CHIMERIC MOUSE-HUMAN IGM ANTI-MUR BY RECOMBINANT TECHNIQUES
HIGHER LEVEL OF MUR ANTIGEN EXPRESSION ON THE RED CELLS OF GP.MUR HOMOZYGOTES THAN THAT OF HETEROZYGOTES
THE DISTRIBUTION OF THE RED CELLS STA (STONES) ANTIGEN IN CHINESE BLOOD DONORS FROM GUANGZHOU
DEVELOPMENT OF REAL-TIME PCR AND MELTING CURVE ANALYSIS FOR THE RAPID DETECTION OF DEL PHENOTYPE
DETECTION OF DEL PHENOTYPE USING ADSORPTION ELUTION TECHNIQUE AND SEQUENCE SPECIFIC PRIMER-POLYMERASE CHAIN REACTION (SSP-PCR)
EXTENDED RED CELL ANTIGEN TYPED REGULAR BLOOD DONORS FOR THALASSEMIC PATIENTS
P-170
EVALUATION OF THE MANAGEMENT WITH CROSSMATCH-COMPATIBLE PLATELET FOR REFRACTORY PATIENTS AND PREVALENCE OF ANTIBODIES DEVELOPED IN THESE PATIENTS
HUMAN PLATELET ANTIGEN (HPA) GENOTYPE AND ANTI-PLATELET ANTIBODY DETERMINATION IN APLASTIC ANEMIA PATIENT
HUMAN PLATELET ANTIGEN DIVERSITY IN PENINSULAR MALAYSIA
ANALYSIS OF ANTI-HPA-1A AND ANTI-NAKA ANTIBODIES ON ENDOTHELIAL FUNCTIONS: IMPACT ON THE PATHOMECHANISM OF FOETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
THE FREQUENCY OF CD36 NEGATIVE INDIVIDUALS AMONG DIFFERENT SOUTH EAST ASIAN POPULATIONS
PLATELET DONOR REGISTRY FOR ALLOIMMUNIZED PATIENTS
A NOVEL GLY540ASN MUTATION ON THE BETA3 SUBUNIT LEADS TO THE PRODUCTION OF ANTI-ALPHAIIBBETA3 AND ANTI-ALPHAVBETA3 ISOANTIBODIES IN PATIENT WITH GLANZMANN THROMBASTHENIA
THE STUDY OF EXPRESSION AND PLATELETS PRESERVE METHOD OF HPA-15 ANTIGEN
THE INFLUENCE OF LEUKODEPLETION OF PLATELET CONCENTRATES ON CD62P EXPRESSION AND CORRECTED COUNT INCREMENT
P-180
RELEVANT ROLE OF TISSUE FACTOR IN VON WILLEBRAND FACTOR-DEPENDENT THROMBUS FORMATION UNDER FLOW: INVOLVEMENT OF INFLAMMATORY RESPONSES BY LEUKOCYTES IN I INTRA-THROMBUS FIBRIN GENERATION
GENERATION OF CYTOKINES IN RED BLOOD CELL PRODUCTS DURING STORAGE: A COMPARISON OF NON- AND LEUKO-REDUCED RED BLOOD CELL COMPONENTS
THE PREVALENCE OF LEUCOCYTE ALLOANTIBODIES IN BLOOD DONORS FROM SOUTH CHINA
HUMAN NEUTROPHIL ANTIGEN FREQUENCIES IN MALAYS AND ORANG ASLI IN PENINSULAR MALAYSIA
FREQUENCY OF HUMAN NEUTROPHIL ANTIGEN-2 AMONG INDIAN BLOOD DONORS
NONINVASIVE FETAL RHD GENOTYPING BY MULTIPLEX REAL-TIME PCR
ANTENATAL SEROLOGY ALGORITHM AND INTRAUTERINE TRANSFUSIONS IN ALLOIMMUNIZED PREGNANCY: NORTH INDIAN TERTIARY CARE CENTRE EXPERIENCE
NEONATAL TRANSFUSION SUPPORT FOR SAFE TRANSFUSION PRACTICE BY TRANSFUSION SERVICE OF REGIONAL UNIVERSITY HOSPITAL
ANALYSIS OF RISK FACTORS ASSOCIATED WITH ALLERGIC TRANSFUSION REACTIONS AND FEBRILE NONHEMOLYTIC TRANSFUSION REACTIONS IN CHILDREN
RED CELL ANTIBODY SCREENING IN PREGNANCY AT A TERTIARY CARE REFERAL HOSPITAL IN SOUTH INDIA: LESSONS LEARNT
RATIONALIZATION AND OPTIMIZATION OF THE THERAPEUTIC PLASMA EXCHANGE APPLICATION
THERAPEUTIC PLASMA EXCHANGE: REVIEW OF THE RESULTS
A CASE SERIES OF THREE PATIENTS UNDERGOING THERAPEUTIC LEUKAPHERESIS IN A TERTIARY CARE HOSPITAL
OPTIMIZING RED CELL EXCHANGE PROCEDURES FOR SICKLE CELL PATIENTS
A CLINICAL AUDIT OF RED CELL TRANSFUSION IN ELECTIVE TOTAL HIP REPLACEMENT SURGERY
RE-EVALUATION OF MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) IN A SECONDARY CARE HOSPITAL IN KOREA
P-197
EFFICACY OF PLATELET CONCENTRATES PREPARED BY RANDOM DONOR BUFFY COAT AND SINGLE DONOR APHERESIS IN ACUTE LEUKEMIA AND CHEMOTHERAPY INDUCED PANCYTOPENIA
BLOOD PRODUCT USAGE IN ADULT PATIENTS WITH MASSIVE BLEEDING
THE EFFECT OF PERI-OPERATIVE ANEMIA AND BLOOD TRANSFUSION ON PATIENTS WITH GASTRIC CANCER RECEIVING GASTRECTOMY
SAVING OUR BLOOD: A BLOOD MANAGEMENT APPROACH IN A REGIONAL HOSPITAL
CLINICAL EFFICACY OF ‘O’ GROUP SINGLE DONOR PLATELETS WITH PLATELET ADDITIVE SOLUTION
ASSESSMENT OF EFFICACY PLATELET TRANSFUSION IN ACUTE LEUKEMIA
UNDER MY SKIN: PRELIMINARY OUTCOMES OF ESTABLISHING A SUBCUTANEOUS IMMUNOGLOBULIN (SCIG) PROGRAM IN A REGIONAL HEALTH SERVICE
P-205
ANALYSIS OF TRANSFUSION ADVERSE REACTIONS TO RED CELL TRANSFUSION IN NATIONAL THALASSAEMIA CENTER TEACHING HOSPITAL KURUNEGALA SRI LANKA
P-207
THE PROGRESS OF THE IMPLEMENTATION OF HOSPITAL TRANSFUSION REACTION REPORTING AND INVESTIGATION SYSTEM
MONITORING NEAR MISS EVENTS IN A HOSPITAL BLOOD BANK
OVERCOMING THE CHALLENGES IN ESTABLISHING A SUCCESSFUL HAEMOVIGILANCE PROGRAMME IN A COUNTRY IN THE ASIAN REGION
ANALYSIS OF SELANGOR STATE HEMOVIGILANCE DATABASE
SETTING AN EFFECTIVE HEMOVIGILANCE SYSTEM IN A HOSPITAL
BLOOD TRANSFUSION AND COMPATIBILIYTY TESTING VALIDITY
INCIDENCE RATE OF TRANSFUSION REACTION FOR PRBC
THE IMMUNOMODULATORY EFFECT OF BONE MARROW MESENCHYMAL STEM CELLS ON EXPRESSION OF TLR3 AND TLR9 IN MICE DENDRITIC CELLS
IMMUNOMODULATORY EFFECTS OF MICE MESENCHYMAL STEM CELLS ON MATURATION AND ACTIVATION OF DENDRITIC CELLS
A REVIEW ON THE EXCLUSION STATUS OF UMBILICAL CORD BLOOD COLLECTIONS IN HONG KONG RED CROSS CATHERINE CHOW CORD BLOOD BANK
DNA METHYL TRANSFERASE 1 EXPRESSION DURING EX VIVO EXPANSION OF UMBILICAL CORD BLOOD-DERIVED HEMATOPOIETIC STEM CELLS
AUTOPHAGY SUPPRESSION IMPROVES REGENERATION POTENTIALITIES OF HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN ACUTE LIVER FAILURE-INDUCED MICE
CHANGE OF RBC DEFORMABILITY DURING HEMATOPOIETIC STEM CELL TRANSPLANTATION
INVESTIGATION OF ERYTHROCYTE DEFORMABILITY OF CHILDREN WITH VARIOUS HEMATOLOGIC DISEASE
A SH-SY5Y DIFFERENTIATED HUMAN NEUROBLASTOMA CELL MODEL TO EVALUATE THE POTENTIAL NEUROPROTECTIVE ROLE OF PLATELET NEUROTROPHINS
USING TWO SOFTWARE TOOLS TO DEFINE HLA CLASS I IMMUNOGENIC EPITOPES OF ANTIBODIES PRODUCED IN ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS
EVALUATION OF HLA ANTIBODY DETECTION RATES IN PATIENTS WITH HEART TRANSPLANTATIONS
CYTOKINE GENE POLYMORPHISMS IN PENINSULAR MALAYSIA